BACKGROUND & AIMS: :Sex hormone signaling regulates a variety of functions in the uterine endometrium essential for embryo implantation and immunity. Epithelial cells of the uterine endometrium are the target of the coordinated actions of estradiol (E(2)) and progesterone. However, little information exists regarding the interplay of estrogens with glucocorticoids in this tissue. Using the human uterine epithelial cell line ECC1, E(2) was found to antagonize induction of the glucocorticoid-induced leucine zipper (GILZ) gene expression, which is associated with several of the immune-related functions of glucocorticoids. Interestingly, E(2) antagonizes glucocorticoid regulated nascent RNA GILZ expression within 1 h of hormone treatment. Repression of glucocorticoid-induced GILZ expression requires the estrogen receptor (ER), because both treatment with the ER-antagonist ICI 182,780 and small interfering RNA knockdown of ERα block E(2)'s ability to repress GILZ gene expression. Antagonism of glucocorticoid-induced GILZ expression may not be unique to ERα, as the ERβ agonist Liquiritigenin is also able to antagonize glucocorticoid signaling. Transcriptional regulation appears to be at the level of promoter binding. Both the glucocorticoid receptor and ERα are recruited to regions of the GILZ promoter containing glucocorticoid response elements and the transcriptional start site. Glucocorticoid receptor binding to these regions in the presence of dexamethasone decreases with E(2) treatment. GILZ gene expression was also found to be repressed in the whole mouse uterus treated with a combination of dexamethasone and E(2). Regulation of the antiinflammatory gene GILZ by glucocorticoids and E(2) suggests cross talk between the immune modulating functions of glucocorticoids and the reproductive actions of estradiol signaling.

背景与目标： 性激素信号调节子宫内膜的多种功能，对胚胎植入和免疫至关重要。子宫内膜的上皮细胞是雌二醇 (E(2)) 和孕酮协同作用的目标。然而，关于该组织中雌激素与糖皮质激素的相互作用的信息很少。使用人子宫上皮细胞系ECC1，发现E(2) 拮抗糖皮质激素诱导的亮氨酸拉链 (GILZ) 基因表达的诱导，这与糖皮质激素的几种免疫相关功能有关。有趣的是，E(2) 在激素治疗后1小时内拮抗糖皮质激素调节的新生RNA GILZ表达。糖皮质激素诱导的GILZ表达的抑制需要雌激素受体 (ER)，因为用ER拮抗剂ICI 182,780治疗和ER α 块E(2) 的小干扰RNA敲除抑制GILZ基因表达的能力。糖皮质激素诱导的GILZ表达的拮抗作用可能不是er α 独有的，因为er β 激动剂Liquiritigenin也能够拮抗糖皮质激素信号传导。转录调控似乎处于启动子结合的水平。糖皮质激素受体和er α 都被募集到含有糖皮质激素反应元件和转录起始位点的GILZ启动子区域。在地塞米松存在下，糖皮质激素受体与这些区域的结合随着E(2) 治疗而降低。还发现在地塞米松和E(2) 联合治疗的整个小鼠子宫中，GILZ基因表达受到抑制。糖皮质激素和E(2) 对抗炎基因GILZ的调节表明，糖皮质激素的免疫调节功能与雌二醇信号传导的生殖作用之间存在串扰。

BACKGROUND & AIMS: :Sex hormone replacement therapy provides several advantages in the quality of life for climacteric women. However, estrogen-induced cell proliferation in the uterus and mammary gland increases the risk of cancer development in these organs. The lower incidence of mammary cancer in Asian women as compared with Western women has been attributed to high intake of soy isoflavones, including genistein. We have previously shown that genistein induces an estradiol-like hypertrophy of uterine cells, but does not induce cell proliferation, uterine eosinophilia, or endometrial edema. It also inhibits estradiol-induced mitosis in uterine cells and hormone-induced uterine eosinophilia and endometrial edema. Nevertheless, genistein stimulates growth of human breast cancer cells in culture; therefore, it is not an ideal estrogen for use in hormone replacement therapy (HRD). The present study investigated the effect of another soy isoflavone, daidzein (subcutaneous, 0.066 mg/kg body weight), in the same animal model, and its effect on responses induced by subsequent treatment (1 h later) with estradiol-17β (E(2); subcutaneous, 0.33 mg/kg body weight). In addition, we investigated the effects of daidzein (1 μg/mL) or E(2) on the growth of human breast cancer cells in culture. Results indicate that daidzein stimulates growth of breast cancer cells and potentiates estrogen-induced cell proliferation in the uterus. We suggest caution for the use of daidzein or formulas containing this compound in HRD. Future research strategies should be addressed in the search for new phytoestrogens that selectively inhibit cell proliferation in the uterus and breast.

背景与目标： : 性激素替代疗法为更年期妇女的生活质量提供了一些优势。然而，雌激素诱导的子宫和乳腺细胞增殖增加了这些器官发生癌症的风险。与西方女性相比，亚洲女性的乳腺癌发病率较低，这归因于大豆异黄酮 (包括染料木黄酮) 的大量摄入。我们以前已经证明，金雀异黄素可诱导子宫细胞的雌二醇样肥大，但不会诱导细胞增殖，子宫嗜酸性粒细胞增多或子宫内膜水肿。它还抑制雌二醇诱导的子宫细胞有丝分裂和激素诱导的子宫嗜酸性粒细胞增多和子宫内膜水肿。然而，金雀异黄素刺激培养物中人类乳腺癌细胞的生长; 因此，它不是用于激素替代疗法 (HRD) 的理想雌激素。本研究调查了另一种大豆异黄酮大豆苷元 (皮下，0.066 mg/kg体重) 在同一动物模型中的作用，及其对随后用雌二醇-17β (E(2) 治疗 (1小时后) 诱导的反应的影响; 皮下，0.33 mg/kg体重)。此外，我们研究了大豆苷元 (1 μ g/mL) 或E(2) 对培养物中人乳腺癌细胞生长的影响。结果表明，大豆苷元刺激乳腺癌细胞的生长并增强雌激素诱导的子宫细胞增殖。我们建议在HRD中使用大豆苷元或含有该化合物的配方谨慎。在寻找选择性抑制子宫和乳房细胞增殖的新型植物雌激素时，应考虑未来的研究策略。

BACKGROUND & AIMS: BACKGROUND:Perineal hernia is well described after standard abdominoperineal excision of rectum. There appears to be an increasing incidence of perineal hernia following extralevator abdominoperineal excision of the rectum. Currently, there is no standard for the prevention of perineal wound herniation and its potential sequelae. Techniques have been described to prevent perineal hernia, including the use of mesh, muscle flaps, or simple layered closure. OBJECTIVE:This technique describes the use of the uterus in postmenopausal women as a "natural packing material" to prevent the small bowel from entering the lower pelvis, and subsequent perineal herniation. PROCEDURE:The procedure involves retroverting the uterus and securing it to the bony pelvis with the use of nonabsorbable suture material. This can be achieved via the abdominal route as well as the perineal wound. LIMITATIONS:This procedure is only applicable in women with uterus in situ. Dyspareunia may be a side effect. Caution is advised in premenopausal women, because positional menstruation may be an issue. Subsequent hysteroscopy and hysterectomy may be difficult. Care should be taken to avoid damage to the presacral venous plexus and sacral nerves. CONCLUSION:Uterine interposition is a practical, low-risk, inexpensive solution to this problem in a selected group of patients. It avoids the cost and complications of prosthetic mesh and myoplastic reconstruction procedures.

背景与目标：

BACKGROUND & AIMS: :A comprehensive immunohistochemistry with the isoform-distinguishable antibodies against prostaglandin (PG) F2α and PGE2 biosynthetic enzymes was undertaken to identify the cellular types and enzyme isoforms in rat ovary and uterus around parturition. In general ovarian and uterine cells showed positive immunoreactions for phospholipase A2 groups 4A and 6A, but not group 2A, and cyclooxygenase (COX)-1 rather than COX-2. Their immunoreactions for PGF2α synthase and PGE2 synthase were cell type-dependently variable. The putative PGF2α and PGE2 producing cell types included, as expected, ovarian luteal cells, uterine endometrial epithelium and myometrium, and cervical connective tissue and, unexpectedly, ovarian stromal cells and basal lamina of cervical endometrium. Obtained data indicate the generation of PGF2α and PGE2 by multiple sites, which are entirely the same as established sites of actions, in parturition processes and tissue-dependent differential usage of PG biosynthetic pathway.

背景与目标： : 采用针对前列腺素 (PG) F2α 和PGE2生物合成酶的亚型可区分抗体进行了全面的免疫组织化学检查，以鉴定分娩前后大鼠卵巢和子宫中的细胞类型和酶同工型。一般而言，卵巢和子宫细胞对磷脂酶A2组4A和6A组显示出阳性免疫反应，但对2A组不显示阳性，以及环氧合酶 (COX)-1而不是COX-2。他们对PGF2α 合酶和PGE2合酶的免疫反应是细胞类型依赖性可变的。如预期的那样，推定的PGF2α 和PGE2产生细胞类型包括卵巢黄体细胞，子宫内膜上皮和子宫肌层，宫颈结缔组织，以及出乎意料的卵巢基质细胞和宫颈子宫内膜基底层。获得的数据表明，在分娩过程和PG生物合成途径的组织依赖性差异使用中，多个位点产生了PGF2α 和PGE2，这些位点与已建立的作用位点完全相同。

BACKGROUND & AIMS: OBJECTIVE:To compare the risk of uterine rupture between a cohort of women with previous low-transverse cesarean section (CS) and a cohort with intact uterus. METHODS:All women with a singleton pregnancy and previous low-transverse CS requiring induction of labor from January 1, 1992 to December 30, 2001 (n = 310) were compared with a cohort of women with intact uterus undergoing induction of labor during the same study period (n = 5420). Protocols of induction using prostaglandin E2 gel and oxytocin infusion were consistent within groups, but differed between the previous CS and the intact uterus group. RESULTS:Uterine rupture occurred in 0.3% in the previous CS group vs. 0.03% in the intact uterus group (p = 0.37). Logistic regression analysis showed no significant difference in rate of uterine rupture between the previous CS vs. intact uterus group (p = 0.16) after controlling for maternal age, parity, gestational age at delivery, Bishop score on admission, use of prostaglandin and oxytocin, and birth weight. Our study had adequate power to detect a 0.38% difference in rate of uterine rupture between the two groups (alpha = 0.05, beta = 0.80). CONCLUSION:Induction of labor is not associated with significantly higher rates of uterine rupture among women with previous low-transverse CS compared with women with intact uterus provided a consistent protocol with strict intervention criteria is adopted.

背景与目标：

BACKGROUND & AIMS: OBJECTIVE:Pelvic radiation therapy (RT) can influence fertility in female rectal cancer survivors. Data regarding its effects on the adult uterus are scant. This study aims to evaluate the uterus before and after RT, using dynamic contrast-enhanced MRI. METHODS:Eligible patients (n=10) received RT for rectal cancer, had an intact uterus and underwent dynamic contrast-enhanced MRI before and after RT. Seven patients were pre-menopausal. RESULTS:Patients received pelvic RT (median, 50.2 Gy) with concurrent 5-fluorouracil. Five patients were treated with intensity modulated RT (IMRT) and five with a three-field technique. The median D95 of the uterus was 30 Gy; D05 was 48 Gy; and V95 was 97%. The median cervical D95 was 45 Gy; D05, 50 Gy; and V95, 100%. Cervical dose was higher with IMRT than with three-field plans (p≤0.038). On T2 MRI, the junctional zone was visible in nine patients before and in one after RT (p=0.001). Median cervical length (2.3 vs 3.0 cm) and endometrial thickness (2.6 vs 5.9 mm) were reduced after RT (p≤0.008). In pre-menopausal patients, the volume transfer constant, K(trans), (0.069 vs 0.195, p=0.006) and the extracellular extravascular volume fraction, V(e), (0.217 vs 0.520, p=0.053) decreased. CONCLUSION:Pelvic RT significantly affected uterine anatomy and perfusion. Cervical dose was higher with IMRT than three-field plans, but no attempt was made to constrain the dose. ADVANCES IN KNOWLEDGE:Pelvic RT significantly affects the adult uterus. These findings are crucial to understand the potential consequences of RT on fertility, and they lay the groundwork for further prospective studies.

背景与目标：

BACKGROUND & AIMS: BACKGROUND:Human umbilical cord mesenchymal stem cell (hUC-MSC) therapy is considered as a promising approach in the treatment of intrauterine adhesions (IUAs). Considerable researches have already detected hUC-MSCs by diverse methods. This paper aims at exploring the quantitative distribution of CM-Dil-labeled hUC-MSCs in different regions of the uterus tissue of the dual injury-induced IUAs in rats and the underlying mechanism of restoration of fertility after implantation of hUC-MSCs in the IUA model. METHODS:In this study, we investigated the quantification of the CM-Dil-labeled hUC-MSCs migrated to the dual injured uterus in Sprague Dawley rats. Additionally, we investigated the differentiation of CM-Dil-labeled hUC-MSCs. The differentiation potential of epithelial cells, vascular endothelial cells, and estrogen receptor (ER) cells were assessed by an immunofluorescence method using CK7, CD31, and ERα. The therapeutic impact of hUC-MSCs in the IUA model was assessed by hematoxylin and eosin, Masson, immunohistochemistry staining, and reproductive function test. Finally, the expression of TGF-β1/Smad3 pathway in uterine tissues was determined by qRT-PCR and Western blotting. RESULTS:The CM-Dil-labeled cells in the stroma region were significantly higher than those in the superficial myometrium (SM) (71.67 ± 7.98 vs. 60.92 ± 3.96, p = 0.005), in the seroma (71.67 ± 7.98 vs. 23.67 ± 8.08, p = 0.000) and in the epithelium (71.67 ± 7.98 vs. 4.17 ± 1.19, p = 0.000). From the 2nd week of treatment, hUC-MSCs began to differentiate into epithelial cells, vascular endothelial cells, and ER cells. The therapeutic group treated with hUC-MSCs exhibited a significant decrease in fibrosis (TGF-β1/Smad3) as well as a significant increase in vascularization (CD31) compared with the untreated rats. CONCLUSION:Our findings suggested that the distribution of the migrated hUC-MSCs in different regions of the uterine tissue was unequal. Most cells were in the stroma and less were in the epithelium of endometrium and gland. Injected hUC-MSCs had a capacity to differentiate into epithelial cells, vascular endothelial cells, and ER cells; increase blood supply; inhibit fibration; and then restore the fertility of the IUA model.

背景与目标：

BACKGROUND & AIMS: :Intravenous leiomyomatosis imitates an invasive malignant tumour both clinically and pathologically although it represents a perfectly benign disease with a favourable outcome. The knowledge of this very rare disease is necessary not to omit the indicated operation on the patient, because of an erroneous assumption of incurability. Therefore, we present the clinical and pathological appearance of this disease from two typical cases of our own.

背景与目标： : 静脉内平滑肌瘤病在临床和病理上都模仿了侵袭性恶性肿瘤，尽管它代表了一种完全良性的疾病，具有良好的疗效。对这种非常罕见的疾病的了解是必要的，不要忽略对患者的指示操作，因为错误的假设是不可治愈的。因此，我们从我们自己的两个典型病例中介绍了这种疾病的临床和病理表现。

BACKGROUND & AIMS: :Benign metastasizing leiomyoma is a rare lesion characterized by benign-appearing smooth muscle tumor most frequently involving the lung and usually associated with a benign leiomyoma or intravenous leiomyomatosis of the uterus. The pathogenetic mechanism of the tumor has not been clarified, but the possibilities including hormone-sensitive in situ proliferations of smooth muscle bundles, mechanical displacement or intravascular spread of preexisting benign uterine tumor tissue, and metastasized very low-grade uterine leiomyosarcoma have been proposed. We described a case of pulmonary benign metastasizing leiomyoma associated with a uterine intravenous leiomyomatosis in a 46-year-old woman with a result of comparative genomic hybridization study. The 2 lesions showed significantly overlapping, if not identical, complex genomic changes in the comparative genomic hybridization, suggesting that the 2 lesions are closely related to each other. Unresected pulmonary nodules were left untreated for 13 months after the hysterectomy and wedge biopsy of 3 pulmonary nodules to show no further growth, suggesting clinical behavior of nonmalignant tumor in our case. Benign metastasizing leiomyomas may comprise a heterogeneous group of tumors in terms of their malignant potential and pathogenetic mechanism.

背景与目标： : 良性转移性平滑肌瘤是一种罕见的病变，其特征是良性出现的平滑肌肿瘤最常累及肺部，通常与良性平滑肌瘤或子宫静脉内平滑肌瘤病有关。肿瘤的发病机制尚未阐明，但已提出了可能的可能性，包括激素敏感的平滑肌束原位增殖，先前存在的良性子宫肿瘤组织的机械移位或血管内扩散以及转移性极低级别子宫平滑肌肉瘤。我们描述了一名46岁女性的肺良性转移性平滑肌瘤与子宫静脉内平滑肌瘤病相关的病例，并进行了比较基因组杂交研究。在比较基因组杂交中，这2个病变显示出明显重叠的复杂基因组变化，即使不相同，也表明这2个病变彼此密切相关。未切除的肺结节在子宫切除术和3个肺结节的楔形活检后未治疗13个月，未显示出进一步的生长，这表明我们的病例是非恶性肿瘤的临床行为。就其恶性潜能和致病机制而言，良性转移性平滑肌瘤可能包含一组异质性肿瘤。

BACKGROUND & AIMS: :Smooth muscle tumours of the uterus are common and the majority are benign leiomyomas. However, there are some tumours which exhibit unusual morphological features or growth patterns that cause difficulty in their distinction from malignant neoplasms and those with endometrial stromal differentiation. Such lesions are reviewed in this article with detailed descriptions of their morphology, differential diagnosis and correlation with biological behaviour.

背景与目标： : 子宫平滑肌肿瘤很常见，大多数是良性平滑肌瘤。然而，有些肿瘤表现出异常的形态特征或生长方式，难以与恶性肿瘤和子宫内膜间质分化的肿瘤区分开来。本文对此类病变进行了综述，并详细描述了其形态，鉴别诊断疾病以及与生物学行为的相关性。

BACKGROUND & AIMS: :We have previously shown that NK lineage cells migrate to the murine decidua of pregnancy; but with advancing gestation, they are progressively inactivated in situ by prostaglandins of the E series (PGE2) secreted by decidual cells and decidual macrophages. We have also shown that the same mechanism inactivates all killer lineage cells in the human decidua, and that this inactivation is at least in part due to a down-regulation of IL-2 receptors and an inhibition of IL-2 production in situ. We examined whether chronic indomethacin therapy (to block prostaglandin synthesis), or a systemic administration of a high dose of IL-2, or a combination of both agents administered to pregnant mice could activate killer cells in situ and interfere with the progress of pregnancy; and if so, whether there was a causal relationship between the two events. Pregnant CD1 mice (Day 5 of gestation) were subjected to chronic indomethacin therapy (14 micrograms/ml in drinking water up to Day 15, or 50 micrograms twice daily sc or ip up to Day 10), high dose IL-2 therapy (25,000 Cetus U of human recombinant IL-2, ip every 8 or 12 hr for 3-5 days), or a combination of the two. These treatments led to pregnancy loss in 89-100% of mice, in contrast to 1% loss in control, vehicle-treated mice. Uterine mononuclear cells isolated from the embryo resorption sites exhibited high killer activity against YAC-1 lymphoma as well as murine trophoblast targets, with NK-like phenotype (Asialo GM-1+, Thy-1-) after indomethacin therapy and LAK-like phenotype (AGM-1+, Thy-1+) after IL-2 or indomethacin + IL-2 therapy. That AGM-1+ killer cells resulted in the pregnancy loss was suggested by the findings that in two of three separate experiments, iv injections of AGM-1 ab into pregnant indomethacin + IL-2-treated mice nearly completely prevented the fetoplacental demise (reducing it to 7.7% from 100%). These results reveal that PGE2-mediated inactivation of killer lineage cells in the decidua in situ is conducive to the survival of the conceptus.

背景与目标： : 我们以前已经证明NK谱系细胞迁移到妊娠的鼠蜕膜; 但是随着妊娠的推进，它们逐渐被蜕膜细胞和蜕膜巨噬细胞分泌的e系列前列腺素 (PGE2) 原位灭活。我们还表明，相同的机制使人蜕膜中的所有杀伤谱系细胞失活，并且这种失活至少部分是由于IL-2受体的下调和原位IL-2产生的抑制。我们检查了慢性吲哚美辛疗法 (阻止前列腺素合成)，或全身施用高剂量的IL-2，或两种药物的组合施用给怀孕小鼠是否可以原位激活杀伤细胞并干扰妊娠进程; 如果是这样，这两个事件之间是否存在因果关系。怀孕的CD1小鼠 (妊娠第5天) 接受慢性吲哚美辛治疗 (14微克/毫升饮用水至第15天，或50微克每日两次sc或ip至第10天)，高剂量IL-2治疗 (25,000人重组IL-2的鲸鱼座U，ip每8或12小时3-5天)，或两者的组合。这些处理导致89-100% 小鼠的妊娠损失，与对照、赋形剂处理的小鼠的1% 损失相反。从胚胎吸收部位分离的子宫单核细胞对YAC-1淋巴瘤和鼠滋养层靶标表现出高杀伤活性，吲哚美辛治疗后具有NK样表型 (Asialo GM-1 +，Thy-1-) 和LAK样表型 (AGM-1 +，thy-1 +) IL-2或吲哚美辛 + IL-2治疗后。AGM-1 + 杀伤细胞导致妊娠损失的研究结果表明，在三个独立实验中的两个实验中，向怀孕的吲哚美辛 + IL-2-treated小鼠静脉注射AGM-1 ab几乎完全阻止了胎儿胎盘的死亡 (将其从100% 减少到7.7%)。这些结果表明，原位蜕膜中杀伤谱系细胞的PGE2-mediated失活有利于概念的存活。

BACKGROUND & AIMS: :Cytogenetic analysis of a uterine leiomyoma from a 56-year-old woman revealed an interstitial deletion of chromosome 10, del(10)(q22q24), as the only chromosomal abnormality. Band 10q22 was also rearranged in a previously reported leiomyosarcoma of the uterus showing a t(10;17)(q22.1;p13) as the only change. These findings provide an additional example in soft tissue tumors for involvement of the same chromosomal regions in benign and malignant proliferation of cells from the same lineage.

背景与目标： : 来自56岁女性的子宫平滑肌瘤的细胞遗传学分析显示，唯一的染色体异常是10号染色体del(10)(q22q24) 的间质缺失。带10q22也在先前报道的子宫平滑肌肉瘤中重新排列，显示t(10;17)(q22.1;p13) 是唯一的变化。这些发现为软组织肿瘤提供了另一个例子，该例子涉及相同谱系细胞的良性和恶性增殖中的相同染色体区域。

BACKGROUND & AIMS: PURPOSE:To evaluate the impact of systemic cyclophosphamide treatment on the rat uterus and investigate the potential therapeutic effects of natural antioxidant preparations curcumin and capsaicin against cyclophosphamide side effects. METHODS:A 40 healthy adult female Wistar albino rats were used in this study. Rats were randomly divided into four groups to determine the effects of curcumin and capsaicin against Cyclophosphamide side effects on the uterus (n=10 in each group); Group 1 was the control group (sham-operated), Group 2 was the cyclophosphamide group, Group 3 was the cyclophosphamide + curcumin (100mg/kg) group, and Group 4 was the cyclophosphamide + capsaicin (0.5 mg/kg) group. RESULTS:Increased tissue oxidative stress and histological damage in the rat uterus were demonstrated due to the treatment of systemic cyclophosphamide chemotherapy alone. The level of tissue oxidant and antioxidant markers and histopathological changes were improved by the treatment of curcumin and capsaicin. CONCLUSION:Cytotoxic effects of natural alkylating chemotherapeutic agents like cyclophosphamide on the uterus can be prevented by curcumin and capsaicin.

背景与目标：

BACKGROUND & AIMS: :Inflammatory myofibroblastic tumor (IMT) is a spindle cell neoplasm with low malignant potential, which may appear in different parts of the body. Uterine localization is rare, especially among children. Etiology is unclear, although some authors suggest underlying trauma or distress. A 3.5-year-old girl was treated at our institute for recurring vaginal bleeding without injury or known pathology. Physical examination and laboratory analysis revealed no specific findings, contrast-enhanced MRI found a 25 × 28 × 30 mm-sized inhomogeneous soft tissue mass in the uterus wall, which was excised in toto. Histological examination identified a spindle cell pattern, and the FISH test revealed ALK gene rearrangement, the lesion was defined as an IMT. Six cases were published to date, and their diagnostic methods are not equivocal, CT, and PET CT were preferred instead of MRI. Aggressive therapy seems to be exaggerated according to low recurrence and metastasis occurrence, and crizotinib is proved as good therapeutic agent in those cases. Biopsy and histology has important role in order to distinguish IMT from malignancies completed with FISH examination because ALK positivity strengthens the diagnosis. No lethal outcome was published among children, as our patient is also symptom-free after 3 years.

背景与目标： : 炎症性肌纤维母细胞瘤 (IMT) 是一种具有低恶性潜能的梭形细胞肿瘤，可能出现在身体的不同部位。子宫定位很少见，尤其是在儿童中。病因尚不清楚，尽管一些作者建议潜在的创伤或困扰。一名3.5岁的女孩在我们研究所接受了复发性阴道出血的治疗，没有受伤或已知的病理。体格检查和实验室检查未发现具体发现，增强MRI在子宫壁中发现25 × 28 × 30毫米大小的不均匀软组织肿块，并在toto中切除。组织学检查确定了梭形细胞模式，FISH测试显示ALK基因重排，病变被定义为IMT。迄今为止已发表了6例病例，其诊断方法并不模棱两可，首选CT和PET CT而不是MRI。根据低复发和转移发生率，积极的治疗似乎被夸大了，在这些情况下，克唑替尼被证明是良好的治疗剂。活检和组织学对于区分IMT和FISH检查完成的恶性肿瘤具有重要作用，因为ALK阳性可增强诊断。在儿童中没有发表致命的结果，因为我们的患者在3年后也没有症状。

BACKGROUND & AIMS: OBJECTIVE:To investigate if an asymmetry exists in the lateral distribution of obstructed hemivagina and renal agenesis in women with uterus didelphys. DESIGN:All English-language medical papers on uterus didelphys, obstructed hemivagina, and associated renal agenesis published from 1980 to 2005 and identified by Embase, Medline, and Pubmed database searches were retrieved. In addition, 41 institutional cases are described. We considered articles in which the presence of a uterus didelphys, obstructed hemivagina, and renal agenesis was assessed as well as the affected side. Data were stratified based on surgical confirmation or imaging evidence of the specific müllerian anomaly. Two authors abstracted data independently on standardized forms, and the combined frequency of right- and left-side malformation subtype was computed. RESULT(S):Thirty-six reports including 138 subjects were selected. Unilateral hemato- or pyocolpos was on the right side in 91 patients (66%). Among the 125 cases with surgical demonstration of the müllerian malformation subtype, 81 (65%) had the anomaly on the right side. In the institutional series, lesions were on the right side in 25 cases (61%). Combining the above figures, the observed proportion of right-sided anomalies (116/179) was 65% (95% CI 57% to 72%). CONCLUSION(S):Left-right asymmetry may be induced before organogenesis, establishing differences in morphogenesis on the left and right sides of the embryo.

背景与目标：